Retracted: Outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen

Authors

  • Chee-Kin Hui,

    Corresponding author
    1. Department of Microbiology, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    2. Research Centre of Infection and Immunology, University of Hong Kong, Hong Kong (Special Adminstrative Region), China
    3. State Key Laboratory of Emerging Infectious Diseases, University of Hong Kong, Hong Kong (Special Adminstrative Region), China
    • Department of Microbiology or Department of Medicine, Queen Mary Hospital, University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR, China
    Search for more papers by this author
    • CKH is an RGC Clinical Research Fellow.

  • Winnie W. Cheung,

    1. Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author
  • Kar-Wai Leung,

    1. Department of Microbiology, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    2. Research Centre of Infection and Immunology, University of Hong Kong, Hong Kong (Special Adminstrative Region), China
    3. State Key Laboratory of Emerging Infectious Diseases, University of Hong Kong, Hong Kong (Special Adminstrative Region), China
    Search for more papers by this author
  • Vincent C. C. Cheng,

    1. Department of Microbiology, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author
  • Bone S. F. Tang,

    1. Department of Microbiology, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author
  • Iris W. S. Li,

    1. Department of Microbiology, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author
  • John M. Luk,

    1. Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author
  • Nikki P. Lee,

    1. Department of Surgery, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author
  • Yok-Lam Kwong,

    1. Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author
  • Wing-Yan Au,

    1. Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author
  • Kwok-Yung Yuen,

    1. Department of Microbiology, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    2. Research Centre of Infection and Immunology, University of Hong Kong, Hong Kong (Special Adminstrative Region), China
    3. State Key Laboratory of Emerging Infectious Diseases, University of Hong Kong, Hong Kong (Special Adminstrative Region), China
    Search for more papers by this author
  • George K. Lau,

    Corresponding author
    1. Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    2. Research Centre of Infection and Immunology, University of Hong Kong, Hong Kong (Special Adminstrative Region), China
    • Department of Microbiology or Department of Medicine, Queen Mary Hospital, University of Hong Kong, 102 Pokfulam Road, Hong Kong SAR, China
    Search for more papers by this author
  • Raymond Liang

    1. Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong (Special Administrative Region), China
    Search for more papers by this author

  • Potential conflict of interest: Nothing to report.

Abstract

Retraction: The following article from HEPATOLOGY, “Outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regiment” by Chee-Kin Hui, Winnie W. Cheung, Kar-Wai Leung, Vincent C. C. Cheng, Bone S. F. Tang, Iris W. S. Li, John M. Luk, Nikki P. Lee, Yok-Lam Kwong, Wing-Yan Au, Kwok-Yung Yuen, George K. Lau, Raymond Liang, published online on 8 January 2008 on Wiley InterScience (www.wileyinterscience.com), has been retracted by agreement between the author, the journal Editor-in-Chief, Keith D. Lindor, and John Wiley & Sons. The article has been retracted at the suggestion of the authors due to irreparable methodological problems.

Ancillary